Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre.
Mark StaresGeorgina LewisMaheva ValletAngus KilleanGiovanni TramontiAilsa PatrizioMelanie MackeanStephen HarrowColin BarrieKirsty MacLennanSorcha CampbellTamasin EvansAisha Tufailnull Edinburgh Cancer Informatics ProgrammePeter S HallIain PhillipsPublished in: Cancers (2023)
The introduction and establishment of SABR for stage I NSCLC has improved survival outcomes in Southeast Scotland. Increasing SABR utilisation appears to have enhanced the selection of surgical patients and increased the proportion of patients receiving a radical therapy.